Abiopharma

Clinical trial NCT03681561: primary completion date: 2026-03-01 → 2026-09-01.

Clinical trial NCT07586202: start date: 2026-07-28 → 2026-07-17.

Clinical trial NCT04924075 updates: 1. completion date: 2029-06-04 → 2029-12-27 2. primary completion date: 2029-06-04 → 2029-12-27 3. enrollment: 322 → 355 participants

Clinical trial NCT05271409 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-12-31 → 2028-05-20

Clinical trial NCT06712654 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-06-01

Clinical trial NCT06975787 updates: 1. completion date: 2028-07-23 → 2029-09-09 2. primary completion date: 2028-07-23 → 2029-09-09

Clinical trial NCT06422520 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-01-31 → 2026-05-15 3. primary completion date: 2026-12-01 → 2026-05-15 4. enrollment: 120 → 63 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT02965755: completion date: 2026-06-01 → 2027-06-01.

Clinical trial NCT02908906: enrollment: 413 → 234 participants.

Clinical trial NCT07519525 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-26 3. primary completion date: 2026-05-01 → 2026-05-26 4. enrollment: 8 → 7 participants 5. enrollment type: ESTIMATED → ACTUAL